Gregory C. Williams
Keine laufenden Positionen mehr
Karriereverlauf von Gregory C. Williams
Ehemalige bekannte Positionen von Gregory C. Williams
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ELOXX PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 29.02.2020 | 01.04.2021 |
Vorstandsvorsitzender | 29.02.2020 | 01.04.2021 | |
Geschäftsführer | 25.06.2018 | 29.02.2020 | |
Technik-/Wissenschafts-/F&E-Leiter | 25.06.2018 | 01.09.2019 | |
RADIUS HEALTH, INC. | Corporate Officer/Principal | 09.01.2014 | 25.05.2018 |
THE MEDICINES COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2006 | 01.01.2013 |
General Counsel | 01.01.2006 | 01.01.2013 | |
NPS PHARMACEUTICALS, INC. | Compliance Officer | 01.01.2004 | 01.01.2006 |
General Counsel | 01.01.2004 | 01.01.2006 |
Ausbildung von Gregory C. Williams
Rutgers State University of New Jersey | Doctorate Degree |
Cornell University | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 6 |
Frankreich | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
General Counsel | 2 |
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ELOXX PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
- Börse
- Insiders
- Gregory C. Williams
- Erfahrung